Plain-English translation of NCT05146336 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a registry — a large database — that tracks how CytoSorb is used in hospitals around the world when treating very sick patients. CytoSorb is a device that filters blood to remove harmful substances during critical illness. By collecting real-world information about how this treatment is used and how patients respond, researchers hope to better understand whether and how it helps improve care.
Many critically ill patients suffer from life-threatening conditions like severe infections, organ failure, or trauma where the body's immune system goes dangerously out of control. This registry exists to gather detailed information about how this treatment performs in everyday hospital practice, so doctors can better understand its benefits and improve care for future patients.
You likely qualify if…
You likely don't qualify if…
If you participate, your medical care team will use the CytoSorb device as part of your treatment in the hospital intensive care unit. Your hospital will share information about your condition, how the treatment was given, and how you responded with the registry database. You won't need to do anything extra — it's simply tracking routine medical information as part of your care.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Austria
Germany